Avera participates in numerous clinical trials, including ones that are Phase 1. In this Avera Medical Minute, we share what ...

We interviewed Sangeeta Shukla, Ph. D., a Bioinformatics Scientist for the Children’s Hospital of Philadelphia. We asked her ...

The NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III ...

Calyx and Invicro businesses officially launched under its new corporate identity, Perceptive. The new name reflects the ...

UCSF officially broke ground on the Barbara and Gerson Bakar Research and Academic Building on Sept. 28, which will house state-of-the-art research facilities, and will also serve as the new home for ...

The agreement focuses on longer visits, preventative care and the health of the patient as a whole. Most of us seek care when ...

The University of the Philippines Manila has developed a medicine for type 2 diabetes, which has shown therapeutic effect on ...

When it comes to clinical research, understanding the journey from initial concept to market approval is essential. At Fusion ...

In 2015, the Lancet Oncology Commission on expanding global access to radiotherapy laid out the first evidence-based case for global investment in radiotherapy by showing substantial health and ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized clinical trial evaluating the efficacy, safety, ...